Neurologist | Neurointensivist | Neurointerventionalist | 🧑‍⚕️👨‍🍼👑

Joined September 2016
Thrilled to see our new SVIN practice update highlighted on the main stage at #SVIN2025 by @svinsociety President Dr. Thanh Nguyen! 🙌🧠 So grateful to @oozaidat and all my mentors 🙏.. proud to contribute to this important work. 🚀💙 #Stroke #NeuroIntervention @SVINJournal
7
1
24
6,499
Amit Chaudhari MD retweeted
FIB-CAS Prospect is a collaborative, multi-site effort to answer an important clinical question in patients with ICAS and AF. One year in & more enrollments ahead. Grateful to every investigator and coordinator helping move the study forward đź§  #Stroke #ICAS #AtrialFibrillation
2
3
1
8
458
Amit Chaudhari MD retweeted
The HALF-IT score, novel simplified MRI-based score for selecting candidates for basilar artery mechanical thrombectomy @oozaidat @Mo_majali91 @NeuroIRdoc
New Research: The HALF-IT score: proposing a simplified mechanical thrombectomy triage tool for basilar artery occlusion www.​frontiersin.​org/articles/10.​3389/fneur.​2026.​1915436 #FrontiersIn #Neurology
2
1
115
Amit Chaudhari MD retweeted
And here's another meta-analysis yet again showing benefit (mRS 0-2) when giving TPA/TNK in the 4.5-24 hour window based on penumbral imaging. When is this going to become mainstream? Thrombolysis in the Delayed Treatment Window for Acute Ischemic Stroke: Updated Systematic Review and Meta-Analysis | @StrokeAHA_ASA ahajournals.org/doi/abs/10.1…
5
23
57
4,859
Amit Chaudhari MD retweeted
I am thrilled to share that the SPIDER-WEB study comparing carotid revasc vs. medical tx in patients with symptomatic carotid webs is complete. The results will be submitted to ISC 2027. We are grateful for the contributing sites. Do you think we have a winner? #stroke #ISC27
7
22
3
112
5,181
Amit Chaudhari MD retweeted
In the landmark CREST-2 study, revascularization did not influence cognition in patients with otherwise asymptomatic carotid stenosis. Read the key results: jwat.ch/4dfphlh
3
1
12
2,176
Mark your calendars for these important dates pertaining to #Match2027. Be sure not to miss the following ERAS submission dates, leading up to the #neurointerventional match!
2
4
481
Amit Chaudhari MD retweeted
SEAL Commercial update - India, here we go! SEAL has received regulatory approval in India! Thank you to our local partners and the Galaxy team for making this milestone possible. #SEAL #GalaxyTherapeutics #India
2
3
179
Amit Chaudhari MD retweeted
Super large bore aspiration catheters (SLACs) in stroke thrombectomy: 📊 A systematic review of 532 patients found ~92% thrombus access, ~55% first-pass effect, and ~81% final near-complete reperfusion, with low complication rates. 🔬 Larger prospective trials are still needed to define their optimal role. Read more here: bit.ly/4hFDTMk
1
9
31
2,789
Amit Chaudhari MD retweeted
A tremendous honor to work with everyone with collaborative expertise here at USC!
Incredible neurovascular program @KeckMedicineUSC featuring #neurosurgery, #neurology & #radiology. David L our superstar #stroke #neurologist starts things off by casting a vision of an NV Operating System. #Brilliant @NeimanHPI @SNISinfo #Neuro
1
5
493
Amit Chaudhari MD retweeted
“A man who fights technology is a man who lost”. Technology is changing how we deliver care. @UofLHealth is proud to partner w/ @penumbrainc, allowing us to bring the most complex, comprehensive, & cutting edge cerebrovascular care in Ohio Valley Region. uoflhealth.org/news/first-in…
1
5
184
Reminder that what we do matters, and when things go wrong we're all affected, and motivated, to do better Thanks to the authors for taking on this important project jnis.bmj.com/content/18/10/1…
1
190
Amit Chaudhari MD retweeted
For patients with acute ischemic stroke, should we extend the time window for intravenous thrombolysis beyond the conventional 4.5 hours? A review and meta-analysis provides new insights. @ChaturvediNeuro share the key results: jwat.ch/4h5R0Ga
4
6
1,748
Not sure what to make of this demographic analysis to predict hemorrhagic transformation post thrombectomy. I think what matters most is what happened in the procedure: number passes, devices used, experience, etc which were entirely unexamined here.. ahajournals.org/doi/full/10.…
165
Antithrombogenic fibrin/heparin coated stent CARESTO for carotid stenosis. Still required 3mo of DAPT. Arguably less in-stent stenosis but difference is minimal, compared to non-coated jnis.bmj.com/content/18/10/1…
163